EU initiative to boost information for patients on medicines development

The EU economy might be splintering apart.  But, meanwhile, a number of patient/public/private organisations are 'euro-zoning' in on the task of providing better information for patients on medicines development. The new initiative - which was launched on 1st February - is called the European Patients Academy on Therapeutic Innovation  or EUPATI for short. Thank goodness they did... Continue Reading →

European patient group directory has some way to go before showing full story on pharma funding

My good colleagues at Cancer52 (the rare cancers coalition) sent me this, the third edition of the Burson-Marsteller directory of patient groups. On a purely practical level this tome is vital in helping to find your way round the various patient groups working on the European stage. Note the introduction by the EU Health Commissioner,... Continue Reading →

Science at the Labour Party Conference – Ed captures hearts but not science

In my potter around the conference exhibition this afternoon, I stumbled upon a stand for the 'People's Museum' here in Manchester which charts the struggles of the working class and houses the Labour Party's official archives. I wish I had time to pop along if only to check whether my knowledge of political history is... Continue Reading →

Venture capitalists weigh in on science funding debate

I spoke at an interesting event last week organised by OneNucleus, a membership organisation which brings together international life science and healthcare companies.  The audience was packed with representatives of both large and small companies including many biotechs.  It was the day before Vince Cable's speech and much concern about what he would or would not... Continue Reading →

Vince Cable on regulatory reform..and more on that single regulator for research idea

You can find the Business Secretary, Vince Cable's, announcement today on regulation on the Department for Business, Innovation and Skills website here. Given the ongoing review of the EU Clinical Trials Directive which I have mentioned a number of times on this blog, many of our members will be pleased with the following statement he... Continue Reading →

Blog at WordPress.com.

Up ↑

%d bloggers like this: